Browse studies

Find your next paid study

135 recruiting studies matching your filters

A Phase I/II Study Evaluating the Safety and the Efficacy of SMART101 Injection to Accelerate Immune Reconstitution After T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric and Adult Patients With Hematological Malignancies

The purpose of this study is to evaluate the safety and the efficacy of SMART101 (Human T Lymphoid Progenitor (HTLP)) injection to accelerate immune reconstitu…

Hematological Malignancies

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Smart Immune SASNCT04959903

UWCCC Precision Medicine Molecular Tumor Board Registry

This study seeks to evaluate the clinical utility of the Precision Medicine Molecular Tumor Board, and to track patient outcomes.

Hematologic NeoplasmsSolid Neoplasm

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Wisconsin, MadisonNCT03023202

Phase 4

Optimizing Antibiotic Selection in Hematologic Malignancy Patients With Reported Beta-lactam Allergy - Intervention

The overall goal of the RENEW-IN intervention is to assess the impact of a BL allergy delabeling intervention on antibiotic use and clinical outcomes in patien…

Beta Lactam AllergyHematologic Malignancy

Estimated

~$25 – $1,000

Actual pay is set by the research site.

Abramson Cancer Center at Penn MedicineNCT07133074

Observational

Design and Implementation of a Social Cognitive Theory-based Medication Adherence Intervention

The goal of this study is to evaluate the effectiveness and usability of a newly developed oral anticancer agent adherence program implemented across 6 cancer …

Solid TumorHematologic Malignancy

Estimated

~$10 – $750

Actual pay is set by the research site.

UNC Lineberger Comprehensive Cancer CenterNCT06989489

Phase 1

A Pilot Study of Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

This research is being done to investigate the safety and effectiveness of Darzalex Faspro (daratumumab and hyaluronidase-fihj) (a monoclonal antibody that tar…

Hematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1

A Phase 1/2, Multicenter, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KK2430 in Participants With Hematologic Neoplasms

KK2430 ("Study Drug") as a potential treatment for people with Hematologic Neoplasms. KK2430 is an experimental drug; it has not been approved for the treatmen…

Hematologic Neoplasms

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Kyowa Kirin Co., Ltd.NCT07629726

Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions

An observational study of patients with hematologic, oncologic, and other relevant conditions undergoing bone marrow imaging, with longitudinal collection of i…

HematologicOncologicBone Marrow

Estimated

~$10 – $750

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT07743476

Global Cardio Oncology Registry

G-COR is the first Global Prospective Cardio-Oncology Registry. It is a multinational, multicenter prospective observational cohort registry, with the goal of …

Breast CancerHematologic MalignancyImmune Checkpoint Inhibitor-Related Myocarditis+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

The Cleveland ClinicNCT05598879

Observational

Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Stem Cell Transplantation

Primary PC - or training HCT clinicians to deliver PC domains as part of routine practice - is an alternative model of supportive care. We have developed Senti…

Hematopoietic Cell TransplantHematologic Malignancy

Estimated

~$10 – $750

Actual pay is set by the research site.

Massachusetts General HospitalNCT06676852

Observational

The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy Period

The purpose of this research study is to see if a virtual reality (VR) headset is useful in reducing physical discomfort and anxiety experienced by patients wh…

Hematologic Malignancy

Estimated

~$10 – $750

Actual pay is set by the research site.

Wake Forest University Health SciencesNCT07203534

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications

This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic maligna…

Hematologic MalignanciesInherited Disorders of MetabolismInherited Abnormalities of Platelets+14 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Phase 1

A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Non-Malignant Disease Using a Reduced-Intensity Preparatory Regime

The hypothesis for this study is that a preparative regimen that maximizes host immunosuppression without myeloablation will be well tolerated and sufficient f…

Metabolic DisordersHematologic, Immune, or Bone Marrow DisordersHemoglobinopathies+1 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Washington University School of MedicineNCT00920972